Medical diagnostics company Omega has launched its rapid antibody test for Covid-19.
The Alva-headquartered company is launching its Mologic ELISA test through its in-house laboratory service in Littleport, Cambridgeshire.
A capillary blood sample collection pack is sent to healthcare professionals, who then send the patient's sample back to the company's laboratory where the test is run.
Test results then go back to each healthcare professional, who informs the patient of their result and provides advice as necessary.
The company expects to offer this testing service to selected commercial occupational health partners, clinics and health care professionals in the UK.
Omega chief executive Colin King said: “We are pleased that we have delivered on our committed timeline for the launch of the lab testing service.
"This highlights our ability to react to changing market needs and utilises the skills and expertise of our long-established service laboratory.”
The announcement comes as the Abingdon Health-led consortium - of which Omega is a part - said it was working on future supply arrangements 27 countries for the separate AbC-19 Rapid Test.
Work is also continuing to build up the data to this test can be used alongside vaccines.
King added: “We welcome the update from Abingdon Health this morning and look forward to being able to update investors on the potential to open up significant commercial opportunities outside of the UK in due course.”
Omega shares rose 2% on early trading this morning.
.jpg?w=600)
